Anti-HER2 drug benefits patients with stomach and bowel cancer
The antibody ZW25 can bind two distinct regions of the HER2 receptor to block the growth of cancer cells and has shown signs of anti-tumour activity...
List view / Grid view
The antibody ZW25 can bind two distinct regions of the HER2 receptor to block the growth of cancer cells and has shown signs of anti-tumour activity...
Medical cannabis is now avaliable through the NHS, but many are warning about its drawbacks and that it won't be available for those who need it...
A study trialling a short course of trastuzumab in HER2 positive breast cancer patients showed that it is as effective and cheaper than a longer course...
A report has suggested that growth of medical cannabis will reach between $11.9 and $17.1 billion by 2020, and is currently around $5 to $6 billion...
A research team from The University of Pennsylvania have analysed the genomic effect of a cancer drug currently in clinical trials...
A cancer vaccine platform could improve the efficacy of oncolytic viruses used in cancer treatment, as shown through a study by Helsinki researchers...
Researchers have presented results of a Phase I clinical trial using bacterial Clostridium novyi-NT spores to target advanced solid tumours...
Portable biopharmaceutical drug manufacturers could be the future method of producing the drugs on demand for outbreaks of disease...
Aluminium could be key for the effective and efficient adsorption of chemotherapy drugs for targeted delivery and reduced side effects...
Researchers questioned whether cancer crowdfunding elicits deception, especially when offering patients treatments with no scientific backing...
Doxorubicin induced irreversible dysregulation which decreased the levels of lipoxygenases and cyclooxygenases in the left ventricle...
Raman spectroscopy can help to detect post-traumatic stress disorder syndrome by revealing the levels of stress hormone in human hair.
The onset of side effects of a common cancer treatment, anti-PD-1 therapy can be identified up to 3 years after treatment...
Watson for Clinical Trial Matching, an AI platform, has shown an increase of 80 percent in enrolment for breast cancer clinical trials, along with reduced screening times for patients...
Scientists are conducting a joint study to develop a radioactive marker, based on nanoparticles, for the detection of cancer...